GlassScriptPhysician profile
Shari Ann Selander-Storm
NPI 1043332059
$1,252.82
in general payments reported to CMS, 2019-2025
18 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $61.10 · 2021: $122 · 2022: $222 · 2023: $233 · 2024: $299 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $712 · Entertainment: $21.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.91 |
| Entertainment | $21.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $286.94 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $193.93 | 2022-2025 | Infuse, Miebo, Xiidra |
| Oyster Point Pharma, INC. | $168.14 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Coopervision INC. | $96.37 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $86.49 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $85.52 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $54.90 | 2021-2022 | |
| Allergan, INC. | $53.34 | 2019-2021 | |
| Alcon Vision LLC | $32.79 | 2025 | Precision7 |
| Lkc Technologies, INC. | $29.63 | 2024 | |
| Abbvie INC. | $25.42 | 2023 | Alphagan P, Vuity, Lumigan |
| Rxsight INC | $25.26 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Optos, INC. | $21.96 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Kala Pharmaceuticals, INC. | $21.70 | 2021 | |
| Sun Pharmaceutical Industries INC. | $21.40 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $18.87 | 2025 | Contact Lens |
| Amgen INC. | $16.08 | 2025 | Tepezza |
| Shire North American Group INC | $14.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shari Selander-Storm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.